Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.
Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
Genes Chromosomes Cancer. 2019 Jun;58(6):373-380. doi: 10.1002/gcc.22727. Epub 2019 Jan 21.
Granular cell tumors (GCTs) are rare mesenchymal tumors that exhibit a characteristic morphology and a finely granular cytoplasm. The genetic alterations responsible for GCT tumorigenesis had been unknown until recently, when loss-of-function mutations of ATP6AP1 and ATP6AP2 were described. Thus, we performed whole-exome sequencing, RNA sequencing, and targeted sequencing of 51 GCT samples. From these genomic analyses, we identified mutations in genes encoding vacuolar H -ATPase (V-ATPase) components, including ATP6AP1 and ATP6AP2, in 33 (65%) GCTs. ATP6AP1 and ATP6AP2 mutations were found in 23 (45%) and 2 (4%) samples, respectively, and all were truncating or splice site mutations. In addition, seven other genes encoding V-ATPase components were also mutated, and three mutations in ATP6V0C occurred on the same amino acid (isoleucine 136). These V-ATPase component gene mutations were mutually exclusive, with one exception. These results suggest that V-ATPase function is impaired in GCTs not only by loss-of-function mutations of ATP6AP1 and ATP6AP2 but also through mutations of other subunits. Our findings provide additional support for the hypothesis that V-ATPase dysfunction promotes GCT tumorigenesis.
颗粒细胞瘤(GCT)是一种罕见的间叶性肿瘤,具有特征性的形态和精细的颗粒状细胞质。直到最近,当描述了 ATP6AP1 和 ATP6AP2 的功能丧失突变时,才知道导致 GCT 肿瘤发生的遗传改变。因此,我们对 51 个 GCT 样本进行了全外显子组测序、RNA 测序和靶向测序。通过这些基因组分析,我们在 33 个(65%)GCT 中鉴定出编码液泡 H+-ATP 酶(V-ATPase)成分的基因突变,包括 ATP6AP1 和 ATP6AP2。在 23 个(45%)和 2 个(4%)样本中分别发现了 ATP6AP1 和 ATP6AP2 突变,且均为截断或剪接位点突变。此外,其他七个编码 V-ATPase 成分的基因也发生了突变,ATP6V0C 中的三个突变发生在相同的氨基酸(异亮氨酸 136)上。这些 V-ATPase 成分基因突变是相互排斥的,只有一个例外。这些结果表明,V-ATPase 功能不仅受到 ATP6AP1 和 ATP6AP2 功能丧失突变的影响,还受到其他亚基突变的影响,在 GCT 中受损。我们的发现为 V-ATPase 功能障碍促进 GCT 肿瘤发生的假说提供了额外的支持。